Honestly? At the start, I almost signed a contract based on nothing but one graphic an agency sent me showing an “85% success rate.” Then I spent two weeks digging into the actual data sources behind Malaysia surrogacy and Russia surrogacy programs, and realized the same phrase “surrogacy success rate” can hide a 20-percentage-point gap. Here’s exactly how I broke the numbers down—run your own check before you sign anything.
Between 85% and 65%: The Difference Is Statistical Definition
The first Malaysia surrogacy promo I saw claimed an 85% success rate. It was only when I flipped to the fine print at the bottom that I noticed—that figure referred to the “positive pregnancy test rate after embryo transfer,” not the take-home baby rate. Roughly 15%-20% of positive pregnancies still end in miscarriage. The Russian reports were more straightforward, quoting live birth rate per transfer: around 60%-65% for surrogate cycles under age 35. Both are called “success,” but one counts a heartbeat on ultrasound and the other counts a baby in your arms. Of course the numbers differ.
Actionable tip: when you ask a clinic or agency for their report, require three definitions in writing—per cycle or per transfer, endpoint at fetal heartbeat or live birth, and the sample size. Any report based on fewer than 200 cycles has limited reference value.
PGT-A Screening Reports: I Only Focused on Two Numbers
My own history: two years, three failed transfers, and finally a diagnosis of immune infertility with elevated NK cells. When I switched to an overseas plan, the clinic recommended going straight to third-generation IVF (PGT-A) to filter out chromosomal issues at the embryo stage first. My screening results on 12 blastocysts: 4 euploid, 3 mosaic, 5 abnormal—a 33% euploid rate. The doctor said that’s completely normal for someone over 35; my earlier transfers without screening were basically shooting blind.
Actionable tip: before signing an agreement with the genetics lab, ask three things—whether the incubators used for blastocyst culture are time-lapse imaging systems, whether mosaic embryos are permitted for transfer, and whether the screening report states the platform and version. These three details directly determine whether the data you receive is trustworthy.
The Surrogate Screening Page: I Read It Line by Line for 40 Minutes
I checked every item on a Russia surrogacy surrogate profile: age 22-28 (mine was 25), at least one full-term vaginal delivery required, BMI capped at 19-26, plus a full panel of eight infectious disease tests, thyroid function, and irregular blood type antibodies. On the Malaysia side, since the law doesn’t open surrogacy to many scenarios beyond heterosexual married couples, many people actually end up doing “travel-to-Malaysia self-carry IVF with PGT-A“—agencies tend to gloss over this, so ask directly.
Actionable tip: when you receive a surrogate’s report, circle three items—gestational age of previous deliveries, number of miscarriages, and whether the psychological evaluation was issued by a third-party organization. If any one is missing, the report is incomplete.
Immune Infertility: 11 Extra Days Before the Cycle, Totally Worth It
After my immune infertility diagnosis, my protocol added two items: two weeks of heparin plus low-dose aspirin before starting the cycle, and an endometrial immunohistochemistry test before transfer. The whole process took 11 days longer than a standard patient’s and cost about 15,000 RMB extra. The result? My second transfer implanted on the first try, with HCG doubling normally. My two earlier unprotected transfers very likely failed at exactly this step.
Actionable tip: if you’ve had 2 or more failed transfers, don’t rush to switch countries or clinics. See a reproductive immunologist first and test four things—NK cells, antiphospholipid antibodies, D-dimer, and the Th1/Th2 ratio. Sometimes the problem isn’t the embryo; it’s the uterine environment.
My advice is simple: before signing, translate “surrogacy success rate” into three questions—definition, sample size, and endpoint; require PGT-A screening reports to specify the platform; and don’t wait until two failures to check your immune infertility markers. Malaysia surrogacy suits people on a budget who can carry their own pregnancy, while Russia surrogacy offers a more complete legal pathway. The finer you break down the data, the fewer traps you’ll fall into.